Nothing Special   »   [go: up one dir, main page]

Mada et al., 2024 - Google Patents

Clostridioides difficile infection

Mada et al., 2024

View HTML
Document ID
15772390185649143657
Author
Mada P
Alam M
Publication year
Publication venue
StatPearls [Internet]

External Links

Snippet

Clostridioides difficile infection - StatPearls - NCBI Bookshelf US flag An official website of the United States government Here's how you know NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation Bookshelf Search database Search term …
Continue reading at www.ncbi.nlm.nih.gov (HTML) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Hybridisation probes
    • C12Q1/6888—Hybridisation probes for detection or identification of organisms
    • C12Q1/689—Hybridisation probes for detection or identification of organisms for bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving viable micro-organisms
    • C12Q1/04—Determining presence or kind of micro-organism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • C12Q1/10—Enterobacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/24—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving viable micro-organisms
    • C12Q1/18—Testing for antimicrobial activity of a material

Similar Documents

Publication Publication Date Title
Sartelli et al. 2019 update of the WSES guidelines for management of Clostridioides (Clostridium) difficile infection in surgical patients
Mada et al. Clostridioides difficile infection
Fatima et al. The hypervirulent strain of Clostridium difficile: NAP1/B1/027-a brief overview
Asempa et al. Clostridium difficile infection in the elderly: an update on management
McFarland et al. Comparison of pediatric and adult antibiotic-associated diarrhea and Clostridium difficile infections
Abad et al. A review of Clostridioides difficile infection and antibiotic-associated diarrhea
Koo et al. Real-Time Polymerase Chain Reaction Detection of Asymptomatic Clostridium difficile Colonization and Rising C. difficile–Associated Disease Rates1
D’Aoust et al. Management of inflammatory bowel disease with Clostridium difficile infection
Rao et al. Fecal microbiota transplantation for the treatment of Clostridium difficile infection
McFarland Renewed interest in a difficult disease: Clostridium difficile infections–epidemiology and current treatment strategies
Bassetti et al. Epidemiology, diagnosis and treatment of Clostridium difficile infection
Kaltsas et al. Clinical and laboratory characteristics of Clostridium difficile infection in patients with discordant diagnostic test results
Mullane et al. Management of Clostridioides (formerly Clostridium) difficile infection (CDI) in solid organ transplant recipients: guidelines from the American Society of Transplantation Community of Practice
Falcone et al. Risk factors and outcomes for bloodstream infections secondary to Clostridium difficile infection
Martínez-Meléndez et al. An update on Clostridioides difficile binary toxin
Meltzer et al. Universal screening for Clostridioides difficile in a tertiary hospital: risk factors for carriage and clinical disease
Chang et al. Increased age and proton pump inhibitors are associated with severe Clostridium difficile infections in children
Kociolek et al. Clinical utility of laboratory detection of Clostridium difficile strain BI/NAP1/027
Plants-Paris et al. Prevalence of Clostridium difficile infections among Kenyan children with diarrhea
Fleece et al. Molecular diagnosis of antimicrobial resistance in Escherichia coli
Walters et al. Clostridium difficile infection: clinical challenges and management strategies
Sullivan et al. Reduced vancomycin susceptibility of methicillin-susceptible Staphylococcus aureus has no significant impact on mortality but results in an increase in complicated infection
Abrahamian et al. Clostridium difficile infection among US emergency department patients with diarrhea and no vomiting
Tabbaa et al. Long-term safety and efficacy of fecal microbiota transplantation in the treatment of Clostridium difficile infection in patients with and without inflammatory bowel disease: a tertiary care center’s experience
Ananthakrishnan et al. Impact of Clostridium difficile on inflammatory bowel disease